Amycretin In Vitro Models: GLP-1 and Amylin Co-Agonism Handling Guidelines
Core Thesis: Amycretin is a first-in-class unimolecular peptide co-agonist that simultaneously activates GLP-1, amylin, and calcitonin receptors. For in vitro characterisation, researchers must account for its complex molecular architecture, receptor subtype selectivity, and specific assay conditions that differ from conventional monoagonist testing. Key handling considerations include receptor subtype-specific cAMP assays, appropriate reference compound selection, and recognition that albumin-free conditions are essential for accurate potency determination. 1. Molecular Architecture and Implications for In Vitro Testing Amycretin (also known as Zenagamtide, NN 9487) is a 68-amino-acid peptide with a molecular weight of approximately 7846.6 Da (free base). Its structure comprises distinct GLP-1 and amylin receptor agonist moieties connected by a linker of four glycine residues and one glutamate residue. The GLP-1 portion incorporates the non-natural amino acid 2-aminoisobutyric a...
